Skip to main content

SV Life Sciences Fund VI, L.P.'s Form 4 filing

TRex Bio, Inc.TRXB · filed Oct 13, 2026

Accession no.
0001829126-26-011084
Filed
Oct 13, 2026, 4:30 PM ET
Trade date
Oct 8-13, 2026
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 7 non-derivative transactions and 5 derivative transactions. Open-market purchases total $1.30M. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
SV Life Sciences Fund VI, L.P.CIK 000164225110% Owner
SVLSF VI, LLCCIK 000171772810% Owner
SV Life Sciences Fund VI (GP), L.P.CIK 000171773010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 8, 2026Common StockPPurchaseAcquired+89,783$14.00+$1,256,962214,869Indirect
Oct 13, 2026Common StockCConversionAcquired+1,574,074$0.00$01,788,943Indirect
Oct 13, 2026Common StockCConversionAcquired+475,411$0.00$02,264,354Indirect
Oct 8, 2026Common StockPPurchaseAcquired+3,074$14.00+$43,0367,356Indirect
Oct 13, 2026Common StockCConversionAcquired+53,892$0.00$061,248Indirect
Oct 13, 2026Common StockCConversionAcquired+16,277$0.00$077,525Indirect
Oct 13, 2026Common StockCConversionAcquired+669,939$0.00$0669,939Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 13, 2026Common StockCConversionDisposed−1,574,074$0.00$00Indirect
Oct 13, 2026Common StockCConversionDisposed−475,411$0.00$00Indirect
Oct 13, 2026Common StockCConversionDisposed−53,892$0.00$00Indirect
Oct 13, 2026Common StockCConversionDisposed−16,277$0.00$00Indirect
Oct 13, 2026Common StockCConversionDisposed−669,939$0.00$00Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)